{"id":"https://openalex.org/W145278646","doi":null,"title":"Synthesis and anticancer activity of nordihydroguaiaretic acid (NDGA) and analogues.","display_name":"Synthesis and anticancer activity of nordihydroguaiaretic acid (NDGA) and analogues.","publication_year":2001,"publication_date":"2001-12-01","ids":{"openalex":"https://openalex.org/W145278646","mag":"145278646","pmid":"https://pubmed.ncbi.nlm.nih.gov/12375879"},"language":"en","primary_location":{"id":"pmid:12375879","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12375879","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drug design","raw_type":"Comparative Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089334436","display_name":"Russell Walker McDonald","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R W McDonald","raw_affiliation_strings":["Department of Chemistry, University of Glasgow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, University of Glasgow, UK","institution_ids":["https://openalex.org/I7882870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037063669","display_name":"W Bunjobpon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W Bunjobpon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100679833","display_name":"Tao Liu","orcid":"https://orcid.org/0000-0002-9663-0378","observed_orcids":["https://orcid.org/0000-0002-9663-0378"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086955406","display_name":"S Fessler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Fessler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063582138","display_name":"Olivier E. Pardo","orcid":"https://orcid.org/0000-0003-2223-1435","observed_orcids":["https://orcid.org/0000-0003-2223-1435"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"O E Pardo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016478612","display_name":"Isabel K. A. Freer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I K Freer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003177986","display_name":"Matthias Glaser","orcid":"https://orcid.org/0009-0008-4463-989X","observed_orcids":["https://orcid.org/0009-0008-4463-989X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Glaser","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001291478","display_name":"Michael J. Seckl","orcid":"https://orcid.org/0000-0002-2032-768X","observed_orcids":["https://orcid.org/0000-0002-2032-768X","https://orcid.org/0000-0003-4078-2599"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M J Seckl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5108292813","display_name":"D. J. ROBINS","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D J Robins","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.5456,"has_fulltext":false,"cited_by_count":38,"citation_normalized_percentile":{"value":0.77385688,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"16","issue":"6","first_page":"261","last_page":"70"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.7294999957084656,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.7294999957084656,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.06360000371932983,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13221","display_name":"Biological Activity of Diterpenoids and Biflavonoids","score":0.06350000202655792,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nordihydroguaiaretic-acid","display_name":"nordihydroguaiaretic acid","score":1.0},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8960000276565552},{"id":"https://openalex.org/keywords/small-cell-lung-cancer","display_name":"small cell lung cancer","score":0.8759999871253967},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.7519999742507935},{"id":"https://openalex.org/keywords/catechol-derivatives","display_name":"catechol derivatives","score":0.7260000109672546},{"id":"https://openalex.org/keywords/conformationally-restricted-analogues","display_name":"conformationally restricted analogues","score":0.8420000076293945},{"id":"https://openalex.org/keywords/lipoxygenase-inhibition","display_name":"lipoxygenase inhibition","score":0.8569999933242798},{"id":"https://openalex.org/keywords/platelet-derived-growth-factor-receptor","display_name":"platelet-derived growth factor receptor","score":0.7910000085830688},{"id":"https://openalex.org/keywords/protein-kinase-c","display_name":"protein kinase C","score":0.8159999847412109},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7099999785423279},{"id":"https://openalex.org/keywords/larrea-divaricata","display_name":"Larrea divaricata","score":0.7919999957084656},{"id":"https://openalex.org/keywords/lead-compounds","display_name":"lead compounds","score":0.6959999799728394}],"concepts":[{"id":"https://openalex.org/C2776889390","wikidata":"https://www.wikidata.org/wiki/Q7050774","display_name":"Nordihydroguaiaretic acid","level":4,"score":0.9880719184875488},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7060566544532776},{"id":"https://openalex.org/C2777713698","wikidata":"https://www.wikidata.org/wiki/Q282440","display_name":"Catechol","level":2,"score":0.5673547387123108},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5198505520820618},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4631141722202301},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.42973899841308594},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3343459665775299},{"id":"https://openalex.org/C2780857362","wikidata":"https://www.wikidata.org/wiki/Q1827455","display_name":"Lipoxygenase","level":3,"score":0.31584909558296204},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.25359177589416504},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.22900575399398804},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.15376868844032288}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009637","descriptor_name":"Masoprocol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D009637","descriptor_name":"Masoprocol","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D009637","descriptor_name":"Masoprocol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010084","descriptor_name":"Oxidation-Reduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016859","descriptor_name":"Lipoxygenase Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D016859","descriptor_name":"Lipoxygenase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018288","descriptor_name":"Carcinoma, Small Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:12375879","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12375879","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drug design","raw_type":"Comparative Study"},{"id":"pmh:oai:eprints.gla.ac.uk:12224","doi":null,"is_oa":false,"landing_page_url":"http://eprints.gla.ac.uk/12224/","pdf_url":null,"source":{"id":"https://openalex.org/S4210235606","display_name":"ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)","issn_l":"2622-8912","issn":["2622-8912","2622-8920"],"is_oa":false,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/I4405259220","host_organization_name":"Institut Agama Islam Negeri Langsa","host_organization_lineage":["https://openalex.org/I4405259220"],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Articles"},{"id":"mag:145278646","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12375879","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2346056021","https://openalex.org/W2981821487","https://openalex.org/W2952832277","https://openalex.org/W2138903833","https://openalex.org/W2346202316","https://openalex.org/W2089090637","https://openalex.org/W2039631871","https://openalex.org/W4285150265","https://openalex.org/W2088409674","https://openalex.org/W2041060214"],"abstract_inverted_index":{"Nordihydroguaiaretic":[0],"acid":[1],"(NDGA)":[2],"1":[3],"is":[4,14,63,72,320],"a":[5,19,240,256,314,328],"constituent":[6],"of":[7,22,52,69,92,109,114,157,193,206,268,301,304,308,331],"the":[8,28,35,84,118,126,145,174,187,211,237,264,278,302,309],"creosote":[9],"bush":[10],"Larrea":[11],"divaricata":[12],"and":[13,34,50,98,133,186,253],"well":[15,73],"known":[16],"to":[17,65,124,134,142,195],"be":[18],"selective":[20],"inhibitor":[21,330],"lipoxygenases.":[23],"NDGA":[24,55,71,93,110,158,168,252,305,326],"can":[25],"also":[26,293],"inhibit":[27],"platelet":[29],"derived":[30],"growth":[31],"factor":[32],"receptor":[33],"protein":[36],"kinase":[37],"C":[38],"intracellular":[39],"signalling":[40],"family,":[41],"which":[42,244,319],"both":[43],"play":[44],"an":[45],"important":[46],"role":[47],"in":[48,58,75,83,122,260],"proliferation":[49],"survival":[51],"cancers.":[53],"Moreover,":[54],"induces":[56],"apoptosis":[57],"tumour":[59],"xenografts.":[60],"Although":[61],"it":[62],"likely":[64],"have":[66,80,105],"several":[67],"targets":[68],"action,":[70],"tolerated":[74],"animals.":[76],"These":[77],"encouraging":[78],"results":[79],"prompted":[81],"interest":[82],"compound":[85,259,270,317],"for":[86,96,129,150],"clinical":[87],"study.":[88],"However,":[89],"high":[90],"concentrations":[91],"are":[94,102,148],"required":[95,128],"efficacy":[97],"more":[99,249,273,323],"potent":[100,234,324],"analogues":[101,108,156,189],"required.":[103],"We":[104],"synthesized":[106],"five":[107,155,180],"with":[111,138,179,191,203,220,239],"different":[112],"lengths":[113],"carbon":[115,183,197],"bridge":[116,242],"between":[117],"two":[119],"catechol":[120,146,175],"moieties":[121,147],"order":[123,141],"establish":[125],"spacing":[127],"optimum":[130],"anticancer":[131,151],"effect":[132],"compare":[135],"their":[136],"activities":[137],"NDGA.":[139,286,297],"In":[140,298],"ascertain":[143],"if":[144],"essential":[149],"activity,":[152,202],"we":[153],"prepared":[154],"containing":[159],"only":[160],"one":[161],"hydroxyl":[162],"group":[163],"on":[164],"each":[165],"aromatic":[166],"ring.":[167],"1,":[169],"its":[170],"racemic":[171],"form":[172],"2,":[173],"derivatives":[176],"5,":[177],"6":[178],"or":[181,223],"six":[182,196],"atom":[184],"bridges":[185,192,225],"phenol":[188],"8-11":[190],"three":[194],"atoms":[198],"all":[199],"showed":[200],"similar":[201],"IC50":[204],"values":[205],"approximately":[207],"3-5":[208],"microM":[209],"against":[210],"H-69":[212,332],"small":[213,333],"cell":[214,217,334],"lung":[215,335],"cancer":[216,336],"line.":[218],"Analogues":[219],"shorter":[221],"(3)":[222],"longer":[224],"(7,":[226],"12)":[227],"were":[228],"much":[229],"less":[230,283,294],"active.":[231],"The":[232,287],"most":[233],"analogue":[235,280,290],"was":[236,245,271,282,292],"biscatechol":[238],"four-carbon":[241],"4":[243],">":[246],"10":[247],"times":[248,322],"active":[250,274,284,295],"than":[251,275,285,296,325],"therefore":[254],"represents":[255],"new":[257,315],"lead":[258,316],"this":[261,269],"area.":[262],"Surprisingly,":[263],"tetramethyl":[265],"ether":[266],"14":[267],"slightly":[272],"NDGA,":[276],"but":[277],"trihydroxy":[279],"13":[281],"conformationally":[288],"restricted":[289],"15":[291],"summary,":[299],"simplification":[300],"structure":[303],"by":[306],"removal":[307],"methyl":[310],"groups":[311],"has":[312],"produced":[313],"4,":[318],">10":[321],"as":[327],"proliferative":[329],"cells.":[337]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}